219 related articles for article (PubMed ID: 31599420)
1. LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC.
Gao YP; Li Y; Li HJ; Zhao B
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7950-7958. PubMed ID: 31599420
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer.
Cheng D; Bao C; Zhang X; Lin X; Huang H; Zhao L
Biomed Pharmacother; 2018 Nov; 107():1540-1547. PubMed ID: 30257372
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
Wu J; Weng Y; He F; Liang D; Cai L
Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-β1.
Huang J; Yu Q; Zhang J; Lu W; Liu Q; Chu Y; Zhou Y; Tu R; Zhou H; Wang Q
Curr Pharm Biotechnol; 2023; 24(8):1059-1069. PubMed ID: 35909269
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
[TBL] [Abstract][Full Text] [Related]
12. Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673.
Wu Y; Niu Y; Leng J; Xu J; Chen H; Li H; Wang L; Hu J; Xia D; Wu Y
Toxicol Lett; 2020 Mar; 320():37-45. PubMed ID: 31778776
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
[TBL] [Abstract][Full Text] [Related]
15. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
16. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
Yue QY; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
[TBL] [Abstract][Full Text] [Related]
17. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
18. LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2-AS1.
Zhang L; Jin C; Yang G; Wang B; Hua P; Zhang Y
BMC Pulm Med; 2020 May; 20(1):153. PubMed ID: 32473628
[TBL] [Abstract][Full Text] [Related]
19. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
